Various compositions for treating a skin or mucosal membrane infection contain glycerol, at least one surfactant, an alcohol, a terpene or terpenoid compound, and a copper compound. The composition contains substantially no water. The glycerol may be at least 31.5% or between about 30% and 80% by weight of the composition, the at least one surfactant may be between about 1% and 10% by weight of the composition, the alcohol may be between about 10% and 50% or between about 20% and 60% by weight of the composition, the terpene or terpenoid compound may be between about 0.5% and 10% by weight of the composition, and the copper compound may be between about 1% and 10% by weight of the composition.

Various compositions for treating a skin or mucosal membrane infection contain glycerol, at least one surfactant, an alcohol, a terpene or terpenoid compound, and a copper compound. The composition contains substantially no water. The glycerol may be at least 31.5% or between about 30% and 80% by weight of the composition, the at least one surfactant may be between about 1% and 10% by weight of the composition, the alcohol may be between about 10% and 50% or between about 20% and 60% by weight of the composition, the terpene or terpenoid compound may be between about 0.5% and 10% by weight of the composition, and the copper compound may be between about 1% and 10% by weight of the composition.

The present invention relates to compounds having a lipid affinity of less than 15% by weight of the compound (such as a log P of −0.75 or less) for use in targeting mitochondria to reduce, inhibit or prevent the formation of mitochondrial reactive oxygen species and for use in treating or preventing a pathological condition associated with increased levels of mitochondrial reactive oxygen species, and for non-therapeutic uses, such as enhancing sports performance and reducing, inhibiting or preventing the formation of mitochondrial reactive oxygen species during exercise, resulting in maintenance of muscle strength and/or a reduction in muscle fatigue, and associated methods. The present invention also relates to extracts and compositions comprising compounds having a lipid affinity of less than 15% (such as a log P of −0.75 or less) for the same uses.

The present invention relates to compounds having a lipid affinity of less than 15% by weight of the compound (such as a log P of −0.75 or less) for use in targeting mitochondria to reduce, inhibit or prevent the formation of mitochondrial reactive oxygen species and for use in treating or preventing a pathological condition associated with increased levels of mitochondrial reactive oxygen species, and for non-therapeutic uses, such as enhancing sports performance and reducing, inhibiting or preventing the formation of mitochondrial reactive oxygen species during exercise, resulting in maintenance of muscle strength and/or a reduction in muscle fatigue, and associated methods. The present invention also relates to extracts and compositions comprising compounds having a lipid affinity of less than 15% (such as a log P of −0.75 or less) for the same uses.

A method for extracting naturally occurring oil bodies (oleosomes) from a material containing naturally occurring oil bodies (oleosomes) includes the steps of dispersing the material containing oleosomes in an aqueous composition to thereby obtain an aqueous dispersion of material containing oleosomes, extracting oleosomes from the aqueous dispersion of material containing oleosomes to thereby obtain a crude oleosome extract and isolating crude oleosomes from the extract by drying the crude oleosome extract. The dried oleosome powder may be used with a personal care product, a pharmaceutical product or a food product.

A method for extracting naturally occurring oil bodies (oleosomes) from a material containing naturally occurring oil bodies (oleosomes) includes the steps of dispersing the material containing oleosomes in an aqueous composition to thereby obtain an aqueous dispersion of material containing oleosomes, extracting oleosomes from the aqueous dispersion of material containing oleosomes to thereby obtain a crude oleosome extract and isolating crude oleosomes from the extract by drying the crude oleosome extract. The dried oleosome powder may be used with a personal care product, a pharmaceutical product or a food product.

A method for treating autoimmune and/or inflammatory disease includes a step of identifying a subject exhibiting symptoms of autoimmune and/or inflammatory disease administering a fasting mimicking diet. A probiotic composition for gastrointestinal autoimmune and/or inflammatory disease Bacteroides acidifaciens, Bifidobacterium choerinum, and combinations thereof is also provided.

A method for treating autoimmune and/or inflammatory disease includes a step of identifying a subject exhibiting symptoms of autoimmune and/or inflammatory disease administering a fasting mimicking diet. A probiotic composition for gastrointestinal autoimmune and/or inflammatory disease Bacteroides acidifaciens, Bifidobacterium choerinum, and combinations thereof is also provided.

An herbal formulation including effective amounts of cat's claw extract, Astragalus extract, Echinacea extract, Moringa extract; astaxanthin, black elderberry extract, vitamin B12, blackseed extract, oregano extract; garlic extract; tumeric extract, and vitamin E provides nutritional support for healthy immune function. The herbal formulation may be packaged in dosage forms that are particularly effective in fighting infections, and especially viral infections.

An herbal formulation including effective amounts of cat's claw extract, Astragalus extract, Echinacea extract, Moringa extract; astaxanthin, black elderberry extract, vitamin B12, blackseed extract, oregano extract; garlic extract; tumeric extract, and vitamin E provides nutritional support for healthy immune function. The herbal formulation may be packaged in dosage forms that are particularly effective in fighting infections, and especially viral infections.